Sign in

CIK 0001776985 · Large accelerated filer

BioNTech SE

Sign in to watch
Ticker
BNTX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Germany
Entity type
other
Phone
0049613190840
Business address
AN DER GOLDGRUBE 12, MAINZ, Germany, 55131
  1. 4 Planned sale Chief Executive Officer sold 63,209 shares at an average $94.07 ($5,945,855)
  2. 4 Planned sale Chief Executive Officer sold 24,000 shares at $95.86 ($2,300,633)
  3. 4 Planned sale Chief Executive Officer sold 93,000 shares at an average $97.14 ($9,033,642)
  4. 4 Planned sale Chief Executive Officer sold 34,000 shares at an average $97.09 ($3,301,069)
  5. 4 Planned sale Chief Executive Officer sold 66,000 shares at an average $98.19 ($6,480,659)
  6. 4 Planned sale Chief Executive Officer sold 61,000 shares at an average $98.57 ($6,012,500)
  7. 4 Planned sale Chief Executive Officer sold 69,000 shares at an average $99.17 ($6,842,742)
  8. 4 Planned sale Chief Executive Officer sold 79,000 shares at an average $99.50 ($7,860,757)
  9. 4 Planned sale Chief Executive Officer sold 64,000 shares at an average $97.49 ($6,239,071)
  10. 4 Planned sale Chief Executive Officer sold 49,000 shares at an average $96.37 ($4,721,976)
  11. 4 Planned sale Chief Executive Officer sold 86,000 shares at an average $98.13 ($8,439,336)
  12. 4 Planned sale Chief Executive Officer sold 20,500 shares at $96.31 ($1,974,287)
  13. 4 Planned sale Chief Executive Officer sold 73,000 shares at an average $98.50 ($7,190,663)
  14. 4 Planned sale Chief Executive Officer sold 76,500 shares at an average $103.12 ($7,889,055)
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 1 of 2 · 36 filings